Treatment of Statin-Induced Necrotizing Autoimmune Myopathy With Glucocorticoid Monotherapy

Copyright © 2020, Lempel et al..

Statins are widely prescribed medications to prevent cardiovascular events such as myocardial infarction and stroke. Both myalgia and myopathy are well-known potential side effects of statins. However, a rare and severe form of statin-induced necrotizing autoimmune myopathy (SINAM) has recently been described and can lead to debilitating weakness, often requiring immunosuppressive therapy. We report a case of a 73-year-old male who made a complete recovery from SINAM following a three-month course of prednisone monotherapy.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:12

Enthalten in:

Cureus - 12(2020), 12 vom: 14. Dez., Seite e12086

Sprache:

Englisch

Beteiligte Personen:

Lempel, Matthew [VerfasserIn]
Molla, Ermal [VerfasserIn]

Links:

Volltext

Themen:

Case Reports
Immune-mediated necrotizing myopathy
Statin-associated autoimmune myopathy
Statin-induced necrotizing autoimmune myopathy

Anmerkungen:

Date Revised 26.01.2021

published: Electronic

Citation Status PubMed-not-MEDLINE

doi:

10.7759/cureus.12086

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM320516059